429 related articles for article (PubMed ID: 9376555)
1. [Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors].
Vogl TJ; Schwarz W; Hammerstingl R; Kümmel S; Balzer JO; Mack MG; Diebold T; Balzer T; Shamsi K; Bechstein WO; Schrem H; Neuhaus P; Felix R
Rofo; 1997 Sep; 167(3):264-73. PubMed ID: 9376555
[TBL] [Abstract][Full Text] [Related]
2. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
Vogl TJ; Hammerstingl R; Keck H; Felix R
Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
4. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
Lee JM; Kim CS; Youk JH; Lee MS
Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629
[TBL] [Abstract][Full Text] [Related]
5. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C
Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
[TBL] [Abstract][Full Text] [Related]
6. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
[TBL] [Abstract][Full Text] [Related]
7. T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules.
Chen RC; Lii JM; Chou CT; Chang TA; Chen WT; Li CS; Tu HY
J Formos Med Assoc; 2008 Oct; 107(10):798-805. PubMed ID: 18926947
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
[TBL] [Abstract][Full Text] [Related]
9. [T1-weighted dynamic MRI with new superparamagnetic iron oxide particles (Resovist): results of a phantom study as well as 25 patients].
Müller M; Reimer P; Wiedermann D; Allkemper T; Marx C; Tombach B; Rummeny EJ; Shamsi K; Balzer T; Peters PE
Rofo; 1998 Mar; 168(3):228-36. PubMed ID: 9551108
[TBL] [Abstract][Full Text] [Related]
10. [New super-paramagnetic iron particles for MRI. Phase II study of malignant liver tumors].
Daldrup HE; Reimer P; Rummeny EJ; Tombach B; Berns T; Balzer T; Schimpfky C; Peters PE
Radiologe; 1995 Aug; 35(8):486-93. PubMed ID: 7568792
[TBL] [Abstract][Full Text] [Related]
11. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
[TBL] [Abstract][Full Text] [Related]
12. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions.
Namkung S; Zech CJ; Helmberger T; Reiser MF; Schoenberg SO
J Magn Reson Imaging; 2007 Apr; 25(4):755-65. PubMed ID: 17335040
[TBL] [Abstract][Full Text] [Related]
13. Clinical results with Resovist: a phase 2 clinical trial.
Reimer P; Rummeny EJ; Daldrup HE; Balzer T; Tombach B; Berns T; Peters PE
Radiology; 1995 May; 195(2):489-96. PubMed ID: 7724772
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227.
Harisinghani MG; Saini S; Weissleder R; Halpern EF; Schima W; Rubin DL; Stillman AE; Sica GT; Small WC; Hahn PF
Radiology; 1997 Mar; 202(3):687-91. PubMed ID: 9051017
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of iron-oxide-enhanced magnetic resonance imaging of the liver: Vessel isointensity is a potential characteristic of liver hemangiomas on late T1-weighted images.
Schmitz SA; Nikolova A; O'Regan D; Albrecht T; Hohmann J; Wolf KJ
Acta Radiol; 2006 Sep; 47(7):634-42. PubMed ID: 16950695
[TBL] [Abstract][Full Text] [Related]
16. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence.
Abe Y; Yamashita Y; Namimoto T; Tang Y; Takahashi M
Radiat Med; 2000; 18(2):97-105. PubMed ID: 10888042
[TBL] [Abstract][Full Text] [Related]
17. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
[TBL] [Abstract][Full Text] [Related]
18. Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions.
Vogl TJ; Hammerstingl R; Schwarz W; Mack MG; Müller PK; Pegios W; Keck H; Eibl-Eibesfeldt A; Hoelzl J; Woessmer B; Bergman C; Felix R
Radiology; 1996 Mar; 198(3):881-7. PubMed ID: 8628887
[TBL] [Abstract][Full Text] [Related]
19. Tumor-liver contrast and subjective tumor conspicuity of respiratory-triggered T2-weighted fast spin-echo sequence compared with T2*-weighted gradient recalled-echo sequence for ferucarbotran-enhanced magnetic resonance imaging of hepatic malignant tumors.
Ishiyama K; Hashimoto M; Izumi J; Watarai J; Shibata S; Sato T; Yamamoto Y
J Magn Reson Imaging; 2008 Jun; 27(6):1322-6. PubMed ID: 18504744
[TBL] [Abstract][Full Text] [Related]
20. [Superparamagnetic iron oxide particles: what value has the T1 effect in the MR diagnosis of focal liver lesions?].
Urhahn R; Adam G; Busch N; Chen JH; Euringer W; Günther RW
Rofo; 1996 Oct; 165(4):364-70. PubMed ID: 8963049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
